Headwinds increased in Q2 as COVID-19 shut down elective procedures and stay-at-home orders impacted trauma volumes, but by the end of the quarter tailwinds picked up and it was smooth flying.
Q220 started out in a stall and continued to nosedive, as the Trauma segment experienced decreased admissions in April and May due to stay at home orders that caused a decrease in daily activities, including limited driving for most of the US. The US Trauma Market was down -14.2% YoY, with WW revenues declining -16.2%.
In June tailwinds picked up as stay at home orders began to lift and activities resumed, which boded well for the Trauma segment. Trauma procedures started to rebound in June, as most hospitals resumed surgeries depending upon PPE and OR time and resources.
Among the many topics covered in the comprehensive Q220 Trauma Market Recap* are:
- Complete Trauma Market Highlights and Overview
- Trauma & Extremities M&A Activity Takes Off
- Journey to Recovery
- Q220 Trauma Regulatory Highlights:
In May Orthopaedic Trauma Association (OTA) held another COVID Webinar to provide updates on how hospitals and surgeons were handling trauma surgeries. During the Webinar, surgeons discussed ...
Read the entire Q220 Trauma Market Recap including news, data, charts, company revenues and analysis*
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.
